Agonist-free transformation of the glucocorticoid receptor in human B-lymphoma cells

被引:6
|
作者
vandenBerg, JD [1 ]
Smets, LA [1 ]
vanRooij, H [1 ]
机构
[1] ANTONI VAN LEEUWENHOEK HOSP,NETHERLANDS CANC INST,DIV EXPTL THERAPY,1066 CX AMSTERDAM,NETHERLANDS
来源
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 1996年 / 57卷 / 3-4期
关键词
D O I
10.1016/0960-0760(95)00271-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nuclear translocation of activated glucocorticoid receptors (GRs) is a necessary step in the signal transduction by these GC hormones. Although in vitro activation of GRs can occur in the absence of a functional ligand, it is generally assumed that binding of a cognate hormone is required for activation of the intracellular GR. By indirect immunocytochemistry and Western-blot analysis, it was found that, in spontaneously aggregated human lymphoma DoHH2 cells, hormone-free GRs are located in the nucleus. Disruption of the aggregates redistributed GRs to a predominantly cytosolic location. Upon spontaneous re-aggregation the GR again became localized to the nucleus. Intracellular cross-linking of the heteromeric receptor complex was applied to investigate the protein composition of cytoplasmic and nuclear receptors. Untransformed, cytosolic GRs could be demonstrated by [H-3]dexamethasone binding capacity and hsp90 co-immunoprecipitation, whereas absence of these characteristics suggested an activated conformation of the nuclear GRs. These observations suggest that cell-cell interactions are capable of transforming GRs in the absence of a ligand. Copyright (C) 1996 Elsevier Science Ltd.
引用
收藏
页码:239 / 249
页数:11
相关论文
共 50 条
  • [31] KINETICS OF THE PLEIOTROPIC EFFECT OF INTERLEUKIN-4 ON THE SURFACE-PROPERTIES OF HUMAN B-LYMPHOMA CELLS
    SHUBINSKY, G
    SCHLESINGER, M
    LEUKEMIA & LYMPHOMA, 1994, 15 (3-4) : 333 - 340
  • [32] A HUMAN B-LYMPHOMA CELL-LINE UNDERGOING SOMATIC MUTATION
    BERINSTEIN, N
    LEVY, S
    LEVY, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 355 - 355
  • [33] Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomib
    Shringarpure, Reshma
    Catley, Laurence
    Bhole, Deepak
    Burger, Renate
    Podar, Klaus
    Tai, Yu-Tzu
    Kessler, Benedikt
    Galardy, Paul
    Ploegh, Hidde
    Tassone, Pierfrancesco
    Hideshima, Teru
    Mitsiades, Constantine
    Munshi, Nikhil C.
    Chauhan, Dharminder
    Anderson, Kenneth C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 134 (02) : 145 - 156
  • [34] USE OF MONODISPERSE, MAGNETIC PARTICLES FOR REMOVAL OF B-LYMPHOMA CELLS FROM HUMAN-BONE MARROW
    KVALHEIM, G
    FODSTAD, O
    NUSTAD, K
    PIHL, A
    FUNDERUD, S
    BRITISH JOURNAL OF CANCER, 1985, 52 (04) : 652 - 652
  • [35] Differential effects of BCL-2 on survival and proliferation of human B-lymphoma cells following γ-irradiation
    Anne E Milner
    Roger JA Grand
    Andrew TM Vaughan
    Richard J Armitage
    Christopher D Gregory
    Oncogene, 1997, 15 : 1815 - 1822
  • [36] TNF-ALPHA THERAPY ACTIVATES HUMAN B-LYMPHOMA CELLS INVIVO AND MAY PROTECT MYELOPOIESIS
    HEILIG, B
    MAPARA, M
    BARGOU, R
    FIEHN, C
    DORKEN, B
    LEUKEMIA RESEARCH, 1992, 16 (08) : 769 - 773
  • [37] OPTIMIZATION OF IMMUNOTHERAPY WITH ADRIAMYCIN(HYDRAZONE)-IMMUNOCONJUGATES IN HUMAN B-LYMPHOMA XENOGRAFTS
    GREENFIELD, RS
    DAUES, A
    EDSON, MA
    GAWLAK, S
    FITZGERALDKADOW, K
    SPITALNY, GL
    WILLNER, D
    BRASLAWSKY, GR
    ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS, 1991, 4 (02): : 107 - 119
  • [38] ANTIGEN PROCESSING AND PRESENTATION BY TRINITROPHENYL (TNP) SPECIFIC B-LYMPHOMA CELLS
    MYERS, CD
    PIIPPO, LJ
    FASEB JOURNAL, 1992, 6 (05): : A2003 - A2003
  • [39] IMMUNOMAGNETIC REMOVAL OF B-LYMPHOMA CELLS FROM HUMAN-BONE MARROW - A PROCEDURE FOR CLINICAL USE
    KVALHEIM, G
    SORENSEN, O
    FODSTAD, O
    FUNDERUD, S
    KIESEL, S
    DORKEN, B
    NUSTAD, K
    JAKOBSEN, E
    UGELSTAD, J
    PIHL, A
    BONE MARROW TRANSPLANTATION, 1988, 3 (01) : 31 - 41
  • [40] Effects of a selective glucocorticoid receptor agonist on osteoblastic and osteoclastic cells
    Rauner, M.
    Finger, S.
    Goettsch, C.
    Benad, R.
    Hofbauer, L. C.
    BONE, 2009, 44 (02) : S312 - S312